COMP <GO>
GRAL vs OSCR // RETURN ON INVESTED CAPITAL (ROIC)
GRAIL Inc. (NASDAQ) VS. Oscar Health Inc. (NYSE) • 15-METRIC TALLY: GRAL 5
— OSCR 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: GRAL
LAST: $133.76 (-6.74%) • MKT CAP: $6.41B
roic
-18.00%
LAST: $31.00 (+2.07%) • MKT CAP: $9.37B
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRAL VS. OSCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRAL | OSCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -18.00% | -35.00% | +17.00 | GRAL | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.23% | 11.51% | -15.74 | OSCR | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 17.20% | 39.00% | -21.80 | OSCR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.26 | 0.45 | +6.81 | GRAL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.0 | 41.9 | +12.10 | GRAL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.97 | +0.03 | GRAL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 23.0x | -1.00 | GRAL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.41B | $9.37B | -$2.97B | OSCR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRAL REV | OSCR REV | GRAL GROSS % | OSCR GROSS % | GRAL FCF | OSCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $147.2M | $28.6M | — | — | -$299.9M | $1.09B |
| FY 2024 | $125.6M | $20.6M | — | — | -$582.4M | $977.3M |
| FY 2023 | $93.1M | $21.4M | — | — | -$600.0M | -$273.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRAL // BETA 1.00
OSCR // BETA 0.97